EF
EMILY FELDER
BROWNSTEIN HYATT FARBER SCHRECK, LLP · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
33
last 3 years
Filings
125
11 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Director of the Office of Legislation
CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee
Disclosed on LD-2 filings
Career
BH
Specific issues
Health data interoperability issues
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse SHARE ACT (HR 1310)
Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain
Issues related to international vaccine deployment
Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing HELP Copays Act
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues S. 476/H.R.5547 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues
Clients
Filing history
PARTICLE HEALTH
NOVARTIS
THE FEDERATION OF STATE MEDICAL BOARDS
RELX INC
MODERNA US INC.
ABBVIE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA
SPARK THERAPEUTICS, INC.
JOHNSON & JOHNSON SERVICES, INC.
NATIONAL MENTOR HOLDINGS, INC.
ELI LILLY AND COMPANY
LIFEPOINT HEALTH